Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NOVO-HYDROXYZIN 50MG CAPSULE Actual shortage 2017-03-13 2020-02-13 1017
NOVO-HYDROXYZIN 25MG CAPSULE Actual shortage 2017-03-13 2017-10-05 1013
NOVO-HYDROXYZIN 10MG CAPSULE Actual shortage 2017-03-10 2017-10-05 159
NOVO-MYCOPHENOLATE 250MG CAPSULE Resolved 2017-03-14 2017-04-25 2278
NOVO-PROFEN 400MG TABLET Resolved 2018-03-13 2018-05-30 42644
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2025-10-01 2025-10-01 268159
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2021-03-11 2021-04-29 135561
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2020-09-24 2020-10-08 124959
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-10-11 2024-11-08 240046
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-10-17 2025-01-30 240525
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-11-28 2025-05-30 244081
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-13 166975
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-13 166972
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-17 166969
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2025-07-29 2025-08-29 263746
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT Resolved 2022-03-04 2022-03-24 156070
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2025-09-19 2025-12-18 267502
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2025-12-18 2025-12-18 274590
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2025-12-18 2025-12-18 274595
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2025-01-09 2025-11-06 247309
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LORAZEPAM 1MG TABLET Discontinued 2025-05-28 2025-05-28 258513
TEVA-LOSARTAN/HCTZ 100MG 12.5MG TABLET Discontinued 2021-02-12 2021-02-12 133896
TEVA-LOSARTAN/HCTZ 100MG 25MG TABLET Discontinued 2021-02-12 2021-02-12 133899
TEVA-LOSARTAN/HCTZ 50.0MG 12.5MG TABLET Discontinued 2021-02-12 2021-02-12 133902
TEVA-MEDROXYPROGESTERONE 2.5MG TABLET Discontinued 2025-04-29 2025-04-29 256113
TEVA-MEDROXYPROGESTERONE 5MG TABLET Discontinued 2025-04-29 2025-04-29 256116
TEVA-MEDROXYPROGESTERONE 10MG TABLET Discontinued 2025-04-29 2025-04-29 256119
TEVA-METFORMIN 500MG TABLET Reversed 2025-05-28 2025-06-04 258452
TEVA-METFORMIN 850MG TABLET Reversed 2025-05-28 2025-06-04 258449
TEVA-METOPROLOL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258537
TEVA-METOPROLOL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258568
TEVA-METOPROLOL 50MG TABLET Discontinued 2020-07-10 2020-07-10 119976
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-05-28 2025-05-28 258535
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2021-02-12 2021-02-12 133908
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-03-20 2025-03-20 253165
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2024-10-11 2024-10-11 240081
TEVA-MIRTAZAPINE 30MG TABLET Reversed 2025-05-28 2025-06-04 258532
TEVA-MODAFINIL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258732
TEVA-NAPROXEN 375MG TABLET Discontinued 2025-05-28 2025-05-28 258493
TEVA-NAPROXEN 250MG TABLET Discontinued 2017-06-27 2017-06-27 14055